NSC |
Compound |
Enrichment |
Correlation |
NSC 704562 |
Null |
0.0135588245836371 |
0.36546816 |
NSC 715724 |
Null |
0.0135588245836371 |
0.15724033 |
NSC 719407 |
Null |
0.0135588245836371 |
0.020974592 |
NSC 727729 |
1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one |
0.0135588245836371 |
0.32954063 |
NSC 732737 |
Null |
0.0135588245836371 |
0.44071843 |
NSC 733891 |
arypurine derivatives |
0.0135588245836371 |
0.31325675 |
NSC 736624 |
Indenoisoquinoline derivative |
0.0135588245836371 |
0.42945946 |
NSC 741106 |
6-(3-Aminopropyl)-5,6-dihydro-9-methoxycarbonyl-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride |
0.0135588245836371 |
0.33010534 |
NSC 658142 |
2-(1-(4-(2-Pyridyl)piperazino))naphthazarin |
0.0141354818755237 |
0.38984409 |
NSC 684836 |
Butanamide, N-[2-[(4-fluorophenyl)amino]-1,1,1,3,3,3- hexafluoro-2-propyl]- |
0.0141354818755237 |
0.31151729 |